The Chinese market for prebiotics is set for substantial expansion through 2026 and beyond, according to Clasado Biosciences, as consumer understanding of gut health continues to mature and evolve.
Following China’s emergence as one of the world’s fastest-growing markets for probiotics, the business predicts that prebiotics will follow a similar trajectory. With the Asia-Pacific prebiotics market valued at USD $2.2 billion in 2020 and expected to grow at a compound annual growth rate of 12.40% between 2025 and 2030 according to intelligence firm Grand View Research, the category shows strong promise for health and nutrition formulators in China.
Marcelo Durante, VP of Sales & Marketing at Clasado Biosciences, explains: “The Chinese market represents an exciting opportunity for prebiotic innovation. We’re seeing clear parallels with the probiotics boom, where heightened consumer awareness of gut health has created substantial market growth. The market’s evolution perfectly demonstrates the sophistication of Chinese consumers – they’re proactively learning more about health matters and willing to pay a premium for products with proven benefits and scientific heritage. Based on trends data, there’s particular interest from Gen Z and Millennials in first-tier cities, who are actively seeking science-backed solutions for gut health.
“Through our distribution partnership with functional ingredient specialist Alliance Nutrition Group, formulators in China can access our prebiotic galactooligosaccharide (GOS) ingredient, Bimuno® GOS, the most studied prebiotic of its kind with over 130 scientific publications and more than 25 clinical trials. What’s particularly compelling is how well this aligns with Chinese consumer preferences – there’s a clear appetite for products that blend modern scientific innovation with health and wellness approaches. With China already accounting for almost a third of the global prebiotic market, and Chinese consumers showing 12% higher willingness to pay for health products compared to the global average, there is appetite for accelerated growth in 2025 and beyond.”
Bimuno GOS differentiates itself through its unique structural composition and production process. Developed using a proprietary enzyme from Bifidobacterium bifidum, it creates a specific mixture of galactooligosaccharides with distinctive beta-linkages that selectively targets beneficial bacteria in the gut. Studies have confirmed that these structural properties enable Bimuno GOS to clinically demonstrate a prebiotic effect in as little as 7 days, significantly faster than alternative options.
The ingredient’s versatility is another key advantage for Chinese formulators. Available in both powder and syrup formats, Bimuno GOS maintains stability across various pH levels and temperatures, making it suitable for a wide range of applications from supplements to functional foods and beverages. This technical flexibility, combined with its low effective daily dose starting from just 1.83g, offers significant formulation advantages in product development.
Kévin Ransbotyn, General Manager of B2B Ingredients at Alliance Nutrition Group, adds: “Chinese consumers are increasingly seeking products with proven scientific backing. This is particularly evident in the gut health category, where there has been remarkable success with probiotics. As understanding grows around how prebiotics can nourish beneficial gut bacteria, we anticipate similar market momentum.
“What’s especially interesting is how the market segments are developing. While digestive health remains core, we’re seeing growing demand from supplement brands and products targeting healthy ageing, in which the gut microbiome plays an important role. A valued approach is demonstrating the importance of a scientifically proven functional ingredient such as Bimuno GOS, while meeting the needs of consumers who are seeking to improve their health and wellbeing through better gut health. Prebiotics that can deliver on both fronts are well-positioned for success in this sophisticated market.”
The growth trajectory mirrors wider trends in Asian nutrition markets, where digestive health products have seen significant uplift. According to Mintel, product launches with digestive health claims in the Asia-Pacific region grew by 23% between 2016 and 2021, indicating strong commercial potential for prebiotic-enhanced products.
Marcelo concludes: “For formulators looking to develop next-generation nutritional products for the Chinese market, prebiotics present an unmissable opportunity. The key will be selecting ingredients with proven stability and scientific backing that can meet the demands of today’s Chinese consumers. As we look ahead, we expect to see continued innovation in prebiotic applications, from supplements to functional foods and beverages.”
To learn more about Bimuno GOS and the science behind it, click here.
